期刊
JOURNAL OF IMMUNOLOGY
卷 195, 期 8, 页码 3685-3693出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1500713
关键词
-
类别
资金
- National Institutes of Health [AI079056, DK083050, 1R01AI107516-01A1, DK-084055/DK/NIDDK NIH HHS/United States]
Alternative NF-kappa B signaling is crucial for B cell activation and Ig production, and it is mainly regulated by the inhibitor of kappa B kinase (IKK) regulatory complex. Dysregulation of alternative NF-kappa B signaling in B cells could therefore lead to hyperactive B cells and Ig overproduction. In our previous, study we found that deleted in breast cancer 1 ( DBC1) is a suppressor of the alternative NF-kappa B pathway to attenuate B cell activation. In this study, we report that loss of DBC1 results in spontaneous overproduction of Ig in mice after 10 mo of age. Using a double mutant genetic model, we confirm that DBC1 suppresses B cell activation through RelB inhibition. At the molecular level, we show that DBC1 interacts with alternative NF-kappa B members RelB and p52 through its leucine zipper domain. In addition, phosphorylation of DBC1 at its C terminus by IKK alpha facilitates its interaction with RelB and IKK alpha, indicating that DBC1-mediated suppression of alternative NF-kappa B is regulated by IKK alpha. Our results define the molecular mechanism of DBC1 inhibition of alternative NF-kappa B activation in suppressing B cell activation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据